Oak Thistle’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,222
Closed -$2.35M – 630
2026
Q2
$2.35M Buy
+17,222
New +$2.12M 0.23% 174
2024
Q4
– Sell
-1,975
Closed -$294K – 528
2024
Q3
$294K Buy
+1,975
New +$283K 0.1% 334

Other funds holding RGEN

Oak Thistle's RGEN Position: Q3 2026 in Review

Oak Thistle sold out of Repligen (RGEN) in Q3 2026, closing a stake of 17,222 shares — an estimated $2.35M sold.

Oak Thistle first reported a position in RGEN in Q3 2024 and held it in 2 quarters. The position peaked at $2.35M in Q2 2026. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Oak Thistle reported no remaining Repligen position as of Q3 2026 after selling out during the quarter.
  • Oak Thistle sold 17,222 Repligen shares in Q3 2026, an estimated $2.35M.
  • Oak Thistle first reported a position in Repligen in Q3 2024 and held it in 2 quarters.
  • Oak Thistle's Repligen position peaked at $2.35M in Q2 2026.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.